Italfarmaco Provides Givinostat Update (January 2018) Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 1:05:09 SMT C1100 – Phase 1 trial results with Summit PMC (December 2012) 12 years ago Research & Clinical Trial Webinars,Webinars 1:00:04 Cardiac Webinar Series: Part 2 – Interventions (November 2012) 12 years ago Care Webinars,Webinars 1:20:12 Direct Access: Sarepta, eteplirsen with Chris Garabedian (October 2012) 12 years ago Research & Clinical Trial Webinars,Webinars 59:07 Cardiac Webinar Series: Part 1 – Monitoring heart disease in Duchenne & carrier moms/daughters (September 2012) 12 years ago Care Webinars,Webinars 1:00:29 Back to School: Special Education & Duchenne (August 2012) 12 years ago Care Webinars,Webinars 59:24 Results from DuchenneConnect Study (April 2012) 13 years ago Research & Clinical Trial Webinars,Webinars 58:43 AVI Clinical Trial Update (March 2012) 13 years ago Research & Clinical Trial Webinars,Webinars 1:08:47 ImagingDMD MRI Study (March 2012) 13 years ago Research & Clinical Trial Webinars,Webinars «1…22232425»Page 24 of 25
by: Parent Project Muscular Dystrophy
